Lataa...
Triple-negative breast cancer: are we making headway at least?
The so-called triple-negative breast cancer, as defined by tumors that lack estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 (HER2) overexpression, has generated growing interest in recent years despite representing less than 20% of all breast cancers. These tumo...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3384094/ https://ncbi.nlm.nih.gov/pubmed/22754593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834012444711 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|